| Dec'19 | ||||||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net income | ||||||
1,160 | ||||||
Adjustments to reconcile net income to net cash used in operating activities: | ||||||
Interest income retained in Trust Account | ||||||
-5,523 | ||||||
Changes in operating assets and liabilities: | ||||||
Increase in prepaid expenses | ||||||
50 | ||||||
Increase in accounts payable | ||||||
46 | ||||||
Increase in accrued liabilities | ||||||
2,116 | ||||||
Increase in deferred compensation | ||||||
116 | ||||||
Net cash used in operating activities | ||||||
-2,135 | ||||||
Cash flows from investing activities: | ||||||
Cash deposited in Trust Account | ||||||
303,152 | ||||||
Cash withdrawn from Trust Account for taxes | ||||||
1,337 | ||||||
Net cash used in investing activities | ||||||
-301,815 | ||||||
Cash flows from financing activities: | ||||||
Proceeds from sale of stock to Anchor Investor | ||||||
3 | ||||||
Proceeds from Note payable to Sponsor | ||||||
210 | ||||||
Proceeds from sale of Units to the public | ||||||
300,150 | ||||||
Proceeds from sale of Private Placement Warrants | ||||||
13,582 | ||||||
Payment of underwriting discounts | ||||||
7,830 | ||||||
Payment of offering costs | ||||||
747 | ||||||
Payment of Note payable to Sponsor | ||||||
300 | ||||||
Net cash provided by financing activities | ||||||
305,068 | ||||||
Net increase (decrease) in cash | ||||||
1,118 | ||||||
Supplemental disclosure of non-cash financing activities: | ||||||
Deferred underwriters' compensation | ||||||
10,179 | ||||||
Cash paid for income taxes | ||||||
1,137 | ||||||